BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 16522164)

  • 1. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
    Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
    Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood].
    Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
    Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
    J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.
    Boxall SA; Cook GP; Pearce D; Bonnet D; El-Sherbiny YM; Blundell MP; Howe SJ; Leek JP; Markham AF; de Wynter EA
    Bone Marrow Transplant; 2009 Apr; 43(8):627-35. PubMed ID: 18997827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low oxygen tension favored expansion and hematopoietic reconstitution of CD34(+) CD38(-) cells expanded from human cord blood-derived CD34(+) Cells.
    Wang Z; Du Z; Cai H; Ye Z; Fan J; Tan WS
    Biotechnol J; 2016 Jul; 11(7):945-53. PubMed ID: 26997358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.